Compare PGEN & CRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PGEN | CRI |
|---|---|---|
| Founded | 1998 | 1865 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Apparel |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.2B |
| IPO Year | 2013 | 2002 |
| Metric | PGEN | CRI |
|---|---|---|
| Price | $4.24 | $37.20 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 5 | 6 |
| Target Price | $8.33 | ★ $35.60 |
| AVG Volume (30 Days) | ★ 3.0M | 1.1M |
| Earning Date | 05-13-2026 | 05-12-2026 |
| Dividend Yield | N/A | ★ 2.74% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.39 |
| Revenue | $230,981,000.00 | ★ $2,898,426,000.00 |
| Revenue This Year | $1,115.92 | $4.57 |
| Revenue Next Year | $81.04 | $1.12 |
| P/E Ratio | ★ N/A | $96.41 |
| Revenue Growth | N/A | ★ 1.91 |
| 52 Week Low | $1.28 | $23.38 |
| 52 Week High | $5.47 | $44.44 |
| Indicator | PGEN | CRI |
|---|---|---|
| Relative Strength Index (RSI) | 52.41 | 56.39 |
| Support Level | $3.97 | $32.34 |
| Resistance Level | $4.40 | $39.54 |
| Average True Range (ATR) | 0.25 | 1.89 |
| MACD | -0.01 | 0.36 |
| Stochastic Oscillator | 30.98 | 68.58 |
Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.
Carter's Inc makes apparel for babies and children under brand names including Carter's and OshKosh B'gosh. It sells its products through a multi-channel business model, which includes retail stores, eCommerce, and wholesale sales channels, as well as retail omnichannel capabilities in the United States and Canada, which enables it to reach a broad range of consumers around the world. The company operates in three segments; U.S. Retail, U.S. Wholesale, and International. The majority of revenue is derived from U.S. Wholesale segment. The company predominantly sources products through contract manufacturers in Asia. It has multiple distribution centers in the U.S., in addition to distribution centers in Canada and Asia that serve international customers.